Scott Howell, Ph.D., CSCS

Scott Howell, Ph.D. is the Research Director of Tier 1 Health and Wellness, Center for Clinical Research. He is an epidemiologist, exercise physiologist and mechanical engineer with research interests in the long-term safety of therapeutic androgen use, endocrine disrupting chemicals exposure, and preventative medicine. His personal interests include research methods, biostatistics, adaptations to physical training, illicit androgen abuse, and philosophy.

Dr. Howell is an author with expertise spanning many fields. His authorships include a recent sport science text, Integrated Periodization in Sports Training and Athletic Development, coauthored with Dr. Tudor Bompa, University of Toronto, and Dr. James Hoffmann, East Tennessee State University. He has also served as a subject matter expert on applied periodization of physical training and the risks involved with illicit doping in sports and bodybuilding. Recently he coauthored the Encyclopedia of Sports Speed for The National Association of Speed and Explosion.

Dr. Howell has published in several notable peer-review journals including the American Journal of Physiology-Endocrinology and Metabolism, Karger Cardiology, Journal of Ethnopharmacology, Pharmacological Research, and the Yale Journal of Biology and Medicine.

Dr. Howell has received numerous acknowledgments for his contributions to academic scholarship and clinical research. He received the American Military University Academic Scholar Award in 2016 and has taken part in two major National Institutes of Health (NIH) and Department of Defense (DoD) funded studies at Wake Forest University: "Strength Training for Arthritis Trial (START)” and “The Runners and Injury Longitudinal Study (TRAILS)."

Dr. Howell holds a Ph.D. in Health Sciences from Trident University, a Master of Science in Sport and Health Science from American Military University, a Bachelor of Science in Sport and Health Science from American Military University, a Mechanical Engineering degree from Forsyth Technical College, and received medical training from BMU School of Medicine.

At Tier 1 Health and Wellness, Dr. Howell conducts research on Endocrine Disrupting Chemicals (EDCs) to measure their impact on men and women’s health. The areas of primary focus are transgenerational effects on sex hormone production and metabolism along with competitive inhibition of AR, ER, and other sex hormone receptors. The aim of the research is to bridge the gap between the literature evidence, current practitioner guidelines, and patients who are adversely affected by EDCs exposure. Dr. Howell implements and plans research at Tier 1 Health and Wellness alongside Dr. Nichols with a common goal of creating awareness of the massive public health problem of EDCs exposure among physicians and the public to enable men and women to be treated effectively when Consensus Guidelines have failed.

Dr. Howell’s most recent thesis and current primary research can be accessed by clicking on the image below.